Avaliaçäo terapêutica do oltipraz na infecçäo humana pelo S. mansoni

Carvalho, Silvino Alves de; Amato Neto, Vicente; Zeitune, José Murilo Robilotta; Yasuda, Maria Aparecida Shikanai; Takiguti, Clovis Kiomitsu.
Rev. Inst. Med. Trop. Säo Paulo ; 28(4): 271-7, jul.-ago. 1986. tab
Artigo em Português | LILACS | ID: lil-33855

Documentos relacionados

  1. [Experience with Selexipag to Treat Pulmonary Arterial Hypertension].
  2. Neuroprotection by tetramethylpyrazine and its synthesized analogues for central nervous system diseases: a review.
  3. Oltipraz: administration with food increases its anti-schistosomal activity.
  4. Circulating antigens for assessing cure in schistosomiasis mansoni.
  5. In vitro and In silico assessment of antischistosomal activities of ethanolic extract of Cornulacamonacantha.
  6. Activities of Quinoxaline, Nitroquinoxaline, and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni.
  7. Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment.
  8. Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration.
  9. Traditional Kenyan herbal medicine: exploring natural products' therapeutics against schistosomiasis.
  10. Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.